| 1 | BLEOMYCIN FOR INJECTION USP 15 UNITS BLEOCEL 15 | Each sterile lyophilized single dose vial contains Bleomycin sulfate USP equivalent to Bleomycin activity | 15 Units |
| 2 | BUSULFAN INJECTION 60mg/10 ml BUSULON 60 | Each ml contains Busulfan USP | 6 mg |
| 3 | CARBOPLATIN INJECTION BP 150 mg/15 ml | Each ml contains Carboplatin BP | 10 mg |
| 4 | CARBOPLATIN INJECTION BP 450 mg/45 ml | Each ml contains Carboplatin BP | 10 mg |
| 5 | CISPLATIN INJECTION BP 10 mg/10 ml | Each ml contains Cisplatin BP Sodium chloride BP | 1 mg, 9mg |
| 6 | CISPLATIN INJECTION BP 50 mg /50 ml | Cisplatin BP Sodium chloride BP | 1 mg, 9mg |
| 7 | CLADRIBINE INJECTION 10 mg/10 Ml | Each ml contains Cladribine USP Sodium Chloride USP | 1 mg, q.s. |
| 8 | CYCLOPHOSPHAMIDE INJECTION IP 500 mg | Each sterile vial contains Cyclophosphamide monohydrate equivalent to Cyclophosphamide | 500 mg |
| 9 | CYCLOPHOSPHAMIDE INJECTION IP 1000 mg | Each sterile vial contains Cyclophosphamide monohydrate equivalent to Cyclophosphamide | 1000 mg |
| 10 | CYTARABINE INJECTION 100 mg/ 1 ml | Each ml contains Cytarabine USP | 100 mg |
| 11 | CYTARABINE INJECTION 500 mg/ 5 ml | Each ml contains Cytarabine USP | 100 mg |
| 12 | CYTARABINE INJECTION 1000 mg/ 10 ml | Each ml contains Cytarabine USP | 100 mg |
| 13 | CYTARABINE INJECTION 2000 mg/ 20 ml | Each ml contains Cytarabine USP | 100 mg |
| 14 | DACARBAZINE FOR INJECTION USP 100 mg | Each sterile lyophilized vial contains Dacarbazine USP | 100 mg |
| 15 | DACARBAZINE FOR INJECTION USP 200 mg | Each sterile lyophilized vial contains Dacarbazine USP | 200 mg |
| 16 | DACARBAZINE FOR INJECTION USP 500 mg | Each sterile lyophilized vial contains Dacarbazine USP | 500 mg |
| 17 | DACTINOMYCIN FOR INJECTION USP 0.5 MG | Each sterile lyophilized vial contains Dactinomycin USP Mannitol USP | 0.5 mg, 20mg |
| 18 | DAUNORUBICIN HYDROCHLORIDE FOR INJECTION USP 20 mg | Each sterile lyophilized vial contains Daunorubicin HYDROCHLORIDE USP equivalent TO Daunorubicin | 20 mg |
| 19 | DOCETAXEL INJECTION CONCENTRATE 20 mg/0.5 ml WITH SOLVENT FOR DOCETAXEL INJECTION CONCENTRTE 20 mg |
Each combipack contains
ONE VIAL OF DOCETAXEL INJECTION CONCENTRATE 20 mg/0.5 ml:
Each sterile vial contains
Anhydrous Docetaxel Polysorbate 80 USNF ONE VIAL OF SOLVENT FOR DOCETAXEL INJECTION CONCENTRATE 20 mg: Each sterile vial contains Alcohol (95% v/v) USP 13% w/v (Absolute alcohol content 15.25 % v/v) Water for injection USP |
20 mg q.s to 0.5 ml
13% w/v q.s to 1.5 ml |
| 20 | DOCETAXEL INJECTION CONCENTRATE 80 mg/2.0 ml WITH SOLVENT FOR DOCETAXEL INJECTION CONCENTRTE 80 mg |
Each combipack contains
ONE VIAL OF DOCETAXEL INJECTION CONCENTRATE 80 mg/2.0 ml:
Each sterile vial contains
Anhydrous Docetaxel
Polysorbate 80 USNF ONE VIAL OF SOLVENT FOR DOCETAXEL INJECTION CONCENTRATE 80 mg: Each sterile vial contains Alcohol (95% v/v) USP (Absolute alcohol content 15.25% v/v) Water for injection USP |
80 mg q.s to 2.0 ml
13% w/v q.s to 6.0 ml |
| 21 | DOCETAXEL INJECTION CONCENTRATE 120 mg/3.0 ml WITH SOLVENT FOR DOCETAXEL INJECTION CONCENTRTE 120 mg |
Each combipack contains
ONE VIAL OF DOCETAXEL INJECTION CONCENTRATE 120 mg/3.0 ml:
Each sterile vial contains
Anhydrous Docetaxel
Polysorbate 80 USNF ONE VIAL OF SOLVENT FOR DOCETAXEL INJECTION CONCENTRATE 120 mg: Each sterile vial contains Alcohol (95% v/v) USP(Absolute alcohol content 15.25% v/v) Water for injection USP |
80 mg q.s to 2.0 ml
13% w/v q.s to 9.0 ml |
| 22 | DOXORUBICIN HYDROCHLORIDE INJECTION USP 10 mg/5 ml | Each ml contains Doxorubicin hydrochloride USP Sodium chloride USP | 2 mg, 9 mg |
| 23 | DOXORUBICIN HYDROCHLORIDE INJECTION USP 50 mg/25 ml | Each ml contains Doxorubicin hydrochloride USP Sodium chloride USP | 2 mg, 9 mg |
| 24 | DOXORUBICIN HYDROCHLORIDE INJECTION USP 10 mg | Each sterile lyophilized vial contains Doxorubicin hydrochloride USP Lactose USP | 10 mg q.s. |
| 25 | DOXORUBICIN HYDROCHLORIDE INJECTION USP 50 mg | Each sterile lyophilized vial contains Doxorubicin hydrochloride USP Lactose USP | 50 mg q.s. |
| 26 | DOXORUBICIN HYDROCHLORIDE LYPOSOMAL INJECTION 20 mg/10 ml | Each ml contains Doxorubicin hydrochloride | 2 mg |
| 27 | DOXORUBICIN HYDROCHLORIDE LYPOSOMAL INJECTION 50 mg/25 ml | Each ml contains Doxorubicin hydrochloride | 2 mg |
| 28 | EPIRUBICIN HYDROCHLORIDE FOR INJECTION 10 mg | Each sterile lyophilized vial contains Epirubicin hydrochloride Ph.Eur Lactose USNF | 10 mg, 50 mg |
| 29 | Each sterile lyophilized vial contains | Epirubicin hydrochloride Ph.Eur Lactose USNF | 50 mg, 250 mg |
| 30 | ETOPOSIDE INJECTION USP 100 mg/5ml | Each ml contains Etoposide USP Benzyl alcohol USP Dehydrated alcohol USP | 20 mg, 30 mg, 30.5% w/v |
| 31 | FLUDARABINE PHOSPHATE FOR INJECTION USP 50 mg | Each sterile lyophilized single dose vial contains Fludarabine phosphate USP Mannitol USP | 50 mg |
| 32 | FLUOROURACIL INJECTION USP 250 mg / 5 ml | Each ml contains Fluorouracil USP | 50 mg |
| 33 | FLUOROURACIL INJECTION USP 500 mg / 10 ml | Each ml contains Fluorouracil USP | 50 mg |
| 33 | FLUOROURACIL INJECTION USP 500 mg / 10 ml | Each ml contains Fluorouracil USP | 50 mg |
| 34 | FOTEMUSTINE FOR INJECTION 200 mg | Each sterile lyophilized vial contains Fotemustine | 200 mg |
| 35 | GEMCITABINE FOR INJECTION USP 200 mg | Each sterile lyophilized vial contains Gemcitabine hydrochloride USP equivalent to Gemcitabine | 200 mg |
| 36 | GEMCITABINE FOR INJECTION USP 1000 mg | Each sterile lyophilized vial contains Gemcitabine hydrochloride USP equivalent to Gemcitabine | 1000 mg |
| 37 | IDARUBICIN HYDROCHLORIDE FOR INJECTION USP 5 mg | Each sterile lyophilized vial contains Idarubicin hydrochloride USP Lactose USNF | 5 mg q.s. |
| 38 | IDARUBICIN HYDROCHLORIDE FOR INJECTION USP 10 mg | Each sterile lyophilized vial contains Idarubicin hydrochloride USP Lactose USNF | 10 mg q.s. |
| 39 | IFOSFAMIDE FOR INJECTION USP 500 mg | Each sterile vial contains Ifosfamide USP | 500 mg |
| 40 | IFOSFAMIDE FOR INJECTION USP 1000 mg | Each sterile vial contains Ifostamide USP | 1000 mg |
| 41 | IFOSFAMIDE FOR INJECTION USP 2000 mg | Each sterile vial contains Ifostamide USP | 1000 mg |
| 42 | IFOSFAMIDE FOR INJECTION USP 3000 mg | Each sterile vial contains Ifostamide USP | 3000 mg |
| 43 | IRINOTECAN HYDROCHLORIDE TRIHYDRATE INJECTION 40 mg/2 ml | Each ml contains Irinotecan Hydrochloride Trihydrate Sorbitol USNF Lactic acid USP | 20 mg, 45 mg, 0.9 mg |
| 44 | IRINOTECAN HYDROCHLORIDE TRIHYDRATE INJECTION 100 mg/5 ml | Each ml contains Irinotecan Hydrochloride Trihydrate Sorbitol USNF Lactic acid USP | 20 mg, 45 mg, 0.9 mg |
| 45 | L-ASPARAGINASE FOR INJECTION 10000 IU | Each sterile lyophilized vial contains L-Asparaginase | 5000 IU |
| 46 | L-ASPARAGINASE FOR INJECTION 10000 IU | Each sterile lyophilized vial contains L-Asparaginase | 10000 IU |
| 47 | METHOTREXATE INJECTION USP 15 mg/ 3 ml | Each ml contains Methotrexate USP Sodium chloride USP Water for injection USP | 5 mg 0.490% w/v q.s |
| 48 | METHOTREXATE INJECTION USP 50 mg/2 ml | Each ml contains Methotrexate USP Sodium chloride USP Water for injection USP | 25 mg 0.490% w/v q.s |
| 49 | METHOTREXATE INJECTION USP 500 mg/5 ml | Each ml contains Methotrexate USP Sodium chloride USP Water for injection USP | 100 mg 0.490% w/v q.s |
| 50 | METHOTREXATE INJECTION USP 1000 mg/10 ml | Each ml contains Methotrexate USP Sodium chloride USP Water for injection USP | 100 mg 0.490% w/v q.s |
| 51 | MELPHALAN FOR INJECTION 50 mg | Each sterile lyophilized vial contains Melphalan USP | 50 mg |
| 52 | MITOMYCIN FOR INJECTION USP 2 mg | Each sterile lyophilized vial contains Metomycin USP Mannitol USP | 2mg, 10 mg |
| 53 | MITOMYCIN FOR INJECTION USP 10 mg | Each sterile lyophilized vial contains Metomycin USP Mannitol USP | 10mg, 20 mg |
| 54 | MITOMYCIN FOR INJECTION USP 20 mg | Each sterile lyophilized vial contains Metomycin USP Mannitol USP | 20mg, 40 mg |
| 55 | MITOMYCIN FOR INJECTION USP 40 mg | Each sterile lyophilized vial contains Metomycin USP Mannitol USP | 40mg, 80 mg |
| 56 | MITOXANTRONE INJECTION USP 20 mg/10 ml | Each ml contains Mitoxantrone hydrochloride USP equivalent to Mitoxantrone free base Sodium chloride USP Water for injection USP | 2mg, 8mg, q.s |
| 57 | MITOXANTRONE INJECTION USP 30 mg/15 ml | Each ml contains Mitoxantrone hydrochloride USP equivalent to Mitoxantrone free base Sodium chloride USP Water for injection USP | 2mg, 8mg, q.s |
| 58 | OXALIPLATIN FOR INJECTION 50 mg | Each sterile lyophilized vial contains Oxaliplatin Ph.Eur Lactose USNF | 50mg, 450mg, |
| 59 | OXALIPLATIN FOR INJECTION 100 mg | Each sterile lyophilized vial contains Oxaliplatin Ph.Eur Lactose USNF | 100mg, 900mg, |
| 60 | PACLITAXEL INJECTION USP 30 mg/5 Ml | Each ml contains Paclitaxel USP Polyoxyl 35 Castor oil USNF Dehydrated alcohol USP | 6mg, 527mg, 49.7% v/v |
| 61 | PACLITAXEL INJECTION USP 100 mg/16.7 ml | Each ml contains Paclitaxel USP Polyoxyl 35 Castor oil USNF Dehydrated alcohol USP | 6mg, 527mg, 49.7% v/v |
| 62 | PACLITAXEL INJECTION USP 150 mg/25 ml | Each ml contains Paclitaxel USP Polyoxyl 35 Castor oil USNF Dehydrated alcohol USP | 6mg, 527mg, 49.7% v/v |
| 63 | PACLITAXEL INJECTION USP 250 mg/41.7 ml | Each ml contains Paclitaxel USP Polyoxyl 35 Castor oil USNF Dehydrated alcohol USP | 6mg, 527mg, 49.7% v/v |
| 64 | PACLITAXEL INJECTION USP 260 mg/43.3 ml | Each ml contains Paclitaxel USP Polyoxyl 35 Castor oil USNF Dehydrated alcohol USP | 6mg, 527mg, 49.7% v/v |
| 65 | PACLITAXEL INJECTION USP 300 mg/50 ml | Each ml contains Paclitaxel USP Polyoxyl 35 Castor oil USNF Dehydrated alcohol USP | 6mg, 527mg, 49.7% v/v |
| 66 | TOPOTECAN HYDROCHLORIDE FOR INJECTION 4 mg | Each sterile lyophilized vial contains Topotecan hydrochloride equivalent to Topotecan | 4 mg |
| 67 | VINBLASTINE SULFATE FOR INJECTION USP 10 mg | Each sterile lyophilized vial contains Vinblastine Sulfate USP | 10 mg |
| 68 | VINCRISTINE SULFATE FOR INJECTION USP 1 mg | Each sterile lyophilized vial contains Vinblastine Sulfate USP | 1mg |
| 69 | VINCRISTINE SULFATE FOR INJECTION USP 2 mg | Each sterile lyophilized vial contains Vinblastine Sulfate USP | 2 mg |
| 70 | VINCRISTINE SULFATE FOR INJECTION USP 1 mg | Each ml contains Vincrystine sulfate USP | 1 mg |
| 71 | VINCRISTINE SULFATE FOR INJECTION USP 2 mg | Each ml contains Vincrystine sulfate USP | 1 mg |
| 72 | VINORELBINE INJECTION USP 10 mg/1 ml | Each ml contains Vinorelbine tartarate USP equivalent to Vinorelbine | 10 mg |
| 73 | VINORELBINE INJECTION USP 50 mg/5 ml | Each ml contains Vinorelbine tartarate USP equivalent to Vinorelbine | 10 mg |
